A recent study has suggested that miR-375 is inhibited by transfection of epithelial-to-mesenchymal transition (EMT), resulting in a reduction of its target thymidylate synthase, which ultimately results in discomfiture of chemoresistance in cancer cells [41]. The gene discussed is TYMS; the disease is cancer.